Mattern J, Bak M, Volm M
Department of Experimental Pathology, German Cancer Research Center, Heidelberg.
Br J Cancer. 1987 Oct;56(4):407-11. doi: 10.1038/bjc.1987.215.
The intrinsic sensitivity of a panel of 8 human epidermoid lung cancer xenografts to vincristine and actinomycin D has been examined and the cross-resistance patterns of the most vincristine-resistant and vincristine-sensitive tumour line were tested to a variety of other drugs, including radiation. The results demonstrate that xenograft lines derived from human lung tumours not previously treated with chemotherapy exhibit a similar general pattern of cross-resistance to the drugs vincristine, actinomycin D and adriamycin as is observed in human cell lines and in animal models selected for resistance to these drugs. It is also shown that intrinsic resistance to vincristine can be partially overcome by verapamil. This may indicate a potential role of this substance in circumventing clinically observed drug resistance.
研究了一组8种人肺表皮样癌异种移植瘤对长春新碱和放线菌素D的内在敏感性,并测试了对长春新碱耐药性最强和敏感性最高的肿瘤细胞系对包括放疗在内的多种其他药物的交叉耐药模式。结果表明,源自未经化疗的人肺肿瘤的异种移植瘤细胞系,与在人类细胞系以及为对这些药物产生耐药性而选择的动物模型中观察到的情况类似,对长春新碱、放线菌素D和阿霉素表现出相似的交叉耐药总体模式。研究还表明,维拉帕米可部分克服对长春新碱的内在耐药性。这可能表明该物质在克服临床观察到的耐药性方面具有潜在作用。